APHB APHB
Set alert
Day range unavailable
52-week range unavailable
More statistics
- Earnings
- May 6, 2019
News
7 years ago businesswire.com
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
SAN DIEGO & LOS ANGELES--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (“AmpliPhi”) (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of precisely targeted…
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018
-
7 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 29th
Stocks Which Set New 52-Week Low Yesterday, October 29th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 23rd
Stocks Which Set New 52-Week Low Yesterday, October 23rd
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 11th
Stocks Which Set New 52-Week Low Yesterday, October 11th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 10th
Stocks Which Set New 52-Week Low Yesterday, October 10th
-
8 years ago benzinga.com
Stocks Which Set New 52-Week Low Yesterday, October 9th
Stocks Which Set New 52-Week Low Yesterday, October 9th
8 years ago businesswire.com
AmpliPhi Biosciences to Hold 2018 First Quarter and Business Update Conference Call on May 15
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections…
8 years ago businesswire.com
AmpliPhi Biosciences Announces Positive Interim Results for Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for…
8 years ago businesswire.com
AmpliPhi Biosciences to Hold 2017 Third Quarter and Business Update Conference Call on November 14
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections…
-
9 years ago benzinga.com
Benzinga's Top Upgrades, Downgrades For August 28, 2017
Benzinga's Top Upgrades, Downgrades For August 28, 2017
9 years ago businesswire.com
AmpliPhi Biosciences to Hold 2017 Second Quarter and Business Update Conference Call on August 14
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies to treat drug-resistant infections using bacteriophage-based technology,…
9 years ago businesswire.com
AmpliPhi Biosciences to Hold Business Update Conference Call on May 15
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
9 years ago businesswire.com
CORRECTING and REPLACING AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01
SAN DIEGO--(BUSINESS WIRE)--Reissuing release to correct ticker symbol for searching purposes. The corrected release reads: AMPLIPHI BIOSCIENCES REPORTS FAVORABLE FINAL RESULTS FROM PHASE 1 TRIAL OF…
10 years ago businesswire.com
AmpliPhi Biosciences Confirms Clinical Trial Progress and Announces Upcoming Conference Call to Provide Corporate Update and Discuss Second Quarter 2016 Financial Results on August 15, 2016
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
10 years ago businesswire.com
AmpliPhi Biosciences to Host Conference Call and Webcast Discussion of First Quarter 2016 Financial Results on May 13, 2016
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
10 years ago businesswire.com
AmpliPhi Biosciences to Host Full-Year 2015 Financial Results Conference Call and Webcast on March 30, 2016
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug-resistant infections, today…
11 years ago businesswire.com
AmpliPhi BioSciences to Host Shareholder Update Conference Call
RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY--(BUSINESS WIRE)--AmpliPhi BioSciences Corporation (OTCQB:APHB) (“AmpliPhi”), the leader in the discovery and development of bacteriophage based therapies…